Notify me when Inspire Investing, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1,104 | $1,111,390,912 | +$253,302,205 | -$172,378,234 | +$80,923,971 | CAT, APH, KLAC, SCHO, IBD | 13F-HR | 17 Feb 2026, 09:30 |
| Q3 2025 | 846 | $1,027,387,702 | +$176,652,876 | -$140,623,768 | +$36,029,108 | CAT, ANET, APH, SCHO, IBD | 13F-HR | 15 Oct 2025, 15:37 |
| Q2 2025 | 824 | $917,957,751 | +$166,451,957 | -$139,276,354 | +$27,175,603 | CAT, WWJD, SCHO, PGR, APH | 13F-HR | 24 Jul 2025, 16:10 |
| Q1 2025 | 800 | $841,290,999 | +$170,395,447 | -$194,801,106 | -$24,405,659 | SCHO, PGR, WWJD, CAT, IBD | 13F-HR | 03 Jun 2025, 13:40 |
| Q4 2024 | 824 | $893,587,915 | +$99,310,708 | -$154,976,914 | -$55,666,206 | USFR, ISRG, CAT, WWJD, ANET | 13F-HR | 17 Jan 2025, 16:13 |
| Q3 2024 | 827 | $977,493,547 | +$210,656,741 | -$150,498,639 | +$60,158,102 | SMCI, IBD, CAT, USFR, ISRG | 13F-HR | 10 Oct 2024, 15:44 |
| Q2 2024 | 802 | $867,646,672 | +$93,542,677 | -$171,097,579 | -$77,554,902 | IBD, USFR, CAT, ISRG, WWJD | 13F-HR | 12 Aug 2024, 17:01 |
| Q1 2024 | 792 | $977,358,548 | +$176,130,353 | -$174,561,535 | +$1,568,818 | CAT, USFR, ISRG, IBD, PGR | 13F-HR | 07 May 2024, 16:51 |
| Q4 2023 | 785 | $909,261,228 | +$127,943,935 | -$87,570,956 | +$40,372,979 | IBD, USFR, CAT, NOW, WWJD | 13F-HR | 12 Feb 2024, 14:43 |
| Q3 2023 | 791 | $783,231,882 | +$147,961,195 | -$156,492,925 | -$8,531,730 | IBD, USFR, CAT, NOW, PLD | 13F-HR | 26 Oct 2023, 11:59 |
| Q2 2023 | 788 | $826,677,093 | +$130,440,620 | -$120,200,844 | +$10,239,776 | IBD, USFR, ISRG, PLD, NOW | 13F-HR | 31 Jul 2023, 10:23 |
| Q1 2023 | 782 | $785,805,315 | +$116,133,024 | -$142,023,007 | -$25,889,983 | USFR, IBD, PLD, ADI, NOW | 13F-HR | 24 Apr 2023, 10:24 |
| Q4 2022 | 743 | $777,062,322 | +$82,947,137 | -$61,451,376 | +$21,495,761 | TFLO, USFR, IBD, WWJD, BLES | 13F-HR | 26 Jan 2023, 14:28 |
| Q3 2022 | 754 | $707,779,000 | +$137,642,915 | -$155,111,720 | -$17,468,805 | USFR, TFLO, IBD, UUP, WWJD | 13F-HR | 07 Nov 2022, 17:01 |
| Q2 2022 | 762 | $753,659,000 | +$170,667,072 | -$154,726,857 | +$15,940,215 | USFR, IBD, UUP, WWJD, BLES | 13F-HR | 10 Aug 2022, 12:37 |
| Q1 2022 | 788 | $864,069,000 | +$154,729,768 | -$102,115,596 | +$52,614,172 | VGSH, IBD, PHYS, BLES, WWJD | 13F-HR | 21 Apr 2022, 10:10 |
| Q4 2021 | 786 | $872,157,000 | +$120,957,252 | -$78,622,234 | +$42,335,018 | IBD, VGLT, ISRG, NOW, PLD | Restatement | 14 Feb 2022, 10:02 |
| Q3 2021 | 794 | $791,140,000 | +$422,059,162 | -$358,578,790 | +$63,480,372 | IBD, VGLT, ISRG, NOW, BLES | 13F-HR | 09 Nov 2021, 14:02 |
| Q2 2021 | 593 | $759,958,000 | +$113,305,915 | -$48,632,967 | +$64,672,948 | NVDA, IBD, BLES, VGLT, ISMD | 13F-HR | 10 Aug 2021, 16:58 |
| Q1 2021 | 597 | $652,117,000 | +$237,021,166 | -$75,886,952 | +$161,134,214 | NVDA, IBD, VGIT, BLES, ISMD | 13F-HR | 30 Apr 2021, 12:07 |
| Q4 2020 | 622 | $452,176,000 | +$140,049,608 | -$98,934,454 | +$41,115,154 | IBD, BLES, NVDA, ISMD, WWJD | 13F-HR | 12 Feb 2021, 14:47 |
| Q3 2020 | 432 | $363,409,000 | +$119,251,970 | -$60,630,488 | +$58,621,482 | VGIT, IBD, BLES, NVDA, WWJD | 13F-HR | 16 Nov 2020, 16:27 |
| Q2 2020 | 485 | $289,563,000 | +$60,285,669 | -$64,577,155 | -$4,291,486 | IBD, BLES, WWJD, ISMD, BIBL | 13F-HR | 12 Aug 2020, 15:46 |
| Q1 2020 | 739 | $250,317,000 | +$76,444,323 | -$43,057,826 | +$33,386,497 | IBD, BLES, WWJD, ISMD, BIBL | 13F-HR | 08 May 2020, 16:44 |
| Q4 2019 | 351 | $278,872,000 | +$20,348,759 | -$22,284,519 | -$1,935,760 | IBD, BLES, ISMD, BIBL, WWJD | 13F-HR | 24 Jan 2020, 12:28 |
| Q3 2019 | 375 | $262,280,000 | +$38,736,964 | -$13,395,090 | +$25,341,874 | IBD, BLES, ISMD, BIBL, UNP | 13F-HR | 13 Nov 2019, 14:18 |
| Q2 2019 | 328 | $237,739,000 | +$29,981,384 | -$10,152,116 | +$19,829,268 | IBD, BLES, ISMD, BIBL, UNP | 13F-HR | 16 Jul 2019, 13:32 |
| Q1 2019 | 297 | $215,351,000 | +$55,953,715 | -$9,255,344 | +$46,698,371 | IBD, BLES, ISMD, BIBL, ABBV | 13F-HR | 16 May 2019, 07:42 |
| Q4 2018 | 242 | $148,727,000 | +$13,982,075 | -$4,659,387 | +$9,322,688 | BLES, IBD, ISMD, BIBL, ABBV | Restatement | 21 Feb 2019, 18:01 |
| Q3 2018 | 237 | $162,265,000 | +$20,782,749 | -$3,865,895 | +$16,916,854 | BLES, IBD, ISMD, BIBL, NVDA | Restatement | 21 Feb 2019, 17:59 |
| Q2 2018 | 220 | $140,705,000 | +$42,082,677 | -$1,567,229 | +$40,515,448 | BLES, IBD, ISMD, BIBL, ABBV | Restatement | 21 Feb 2019, 17:59 |
| Q1 2018 | 199 | $98,156,000 | +$17,351,232 | -$35,566,220 | -$18,214,988 | BLES, IBD, ISMD, BIBL, ITW | Restatement | 21 Feb 2019, 21:04 |
| Q4 2017 | 913 | $117,527,000 | $0 | $0 | $0 | BLES, IBD, ISMD, BIBL, NUE | Restatement | 21 Feb 2019, 17:49 |